- Home
- MRVI vs AZUL Comparison
MRVI vs AZUL Comparison
Compare MRVI & AZUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- AZUL
- Stock Information
- Founded
- MRVI 2014
- AZUL 2008
- Country
- MRVI United States
- AZUL Brazil
- Employees
- MRVI N/A
- AZUL N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- AZUL Air Freight/Delivery Services
- Sector
- MRVI Health Care
- AZUL Consumer Discretionary
- Exchange
- MRVI Nasdaq
- AZUL Nasdaq
- Market Cap
- MRVI 262.9M
- AZUL 271.1M
- IPO Year
- MRVI 2020
- AZUL 2017
- Fundamental
- Price
- MRVI $2.12
- AZUL $0.64
- Analyst Decision
- MRVI Hold
- AZUL Hold
- Analyst Count
- MRVI 9
- AZUL 8
- Target Price
- MRVI $6.54
- AZUL $4.67
- AVG Volume (30 Days)
- MRVI 1.7M
- AZUL 13.0M
- Earning Date
- MRVI 05-12-2025
- AZUL 05-20-2025
- Dividend Yield
- MRVI N/A
- AZUL N/A
- EPS Growth
- MRVI N/A
- AZUL N/A
- EPS
- MRVI N/A
- AZUL N/A
- Revenue
- MRVI $259,185,000.00
- AZUL $3,157,077,406.00
- Revenue This Year
- MRVI N/A
- AZUL N/A
- Revenue Next Year
- MRVI $11.14
- AZUL $8.77
- P/E Ratio
- MRVI N/A
- AZUL N/A
- Revenue Growth
- MRVI N/A
- AZUL 5.24
- 52 Week Low
- MRVI $1.67
- AZUL $0.48
- 52 Week High
- MRVI $11.56
- AZUL $6.64
- Technical
- Relative Strength Index (RSI)
- MRVI 50.73
- AZUL 22.91
- Support Level
- MRVI $1.96
- AZUL $0.63
- Resistance Level
- MRVI $2.16
- AZUL $0.79
- Average True Range (ATR)
- MRVI 0.12
- AZUL 0.16
- MACD
- MRVI 0.04
- AZUL -0.02
- Stochastic Oscillator
- MRVI 65.31
- AZUL 14.07
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About AZUL Azul S.A. (each representing three preferred shares)
Azul SA is involved in the operation of regular and non-regular airline passenger services, cargo or mail, passenger charter, provision of maintenance and hangarage services for aircraft, engines, parts and pieces, aircraft acquisition and lease, development of frequent-flyer programs, development of related activities and equity holding in other companies. The Company considers that it has a single reportable segment which is air transport.